Condition
Stage III Non-small Cell Lung Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Stage III Non-small Cell Lung Cancer clinical trials that are recruiting, at sites in 6 countries (most in Germany (1), Switzerland (1), Netherlands (1)). By phase: Phase 2 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 6Countries
Newest Stage III Non-small Cell Lung Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Cemiplimab guided by ctDNA levels (PALACE) | Phase 2 | Alicante, Alicante and 19 other locations | Recruiting | Apr 8, 2025 |
| Accelerated immuno chemoradiotherapy for advanced lung cancer | Phase 2 | Dresden and 10 other locations | Recruiting | Oct 26, 2023 |
| Using PET/CT scans to improve follow-up care for stage III lung cancer patients | — | Hilversum, Utrecht and 26 other locations | Recruiting | Oct 13, 2023 |
| Infusion of IOV-4001 for advanced melanoma and lung cancer | Phase 1/2 | Los Angeles, California and 10 other locations | Recruiting | May 4, 2022 |
| New radiotherapy approach for advanced lung cancer | — | Aarhus | Recruiting | Nov 15, 2018 |
All recruiting trials (5)
-
Cemiplimab guided by ctDNA levels (PALACE)
This study will see if starting adults with advanced (stage IIIB/C or IV) non-small cell lung cancer and PD-L1 ≥50% on cemiplimab, then using ctDNA and early scans to decide whether to add chemotherapy, can improve overall survival.
-
Accelerated immuno chemoradiotherapy for advanced lung cancer
This study is testing a new fast treatment combining radiation and chemotherapy for people with advanced lung cancer to see if it works better than the usual approach.
-
Using PET/CT scans to improve follow-up care for stage III lung cancer patients
This study is testing if using special PET/CT scans can help stage III lung cancer patients live longer and have better follow-up care compared to regular CT scans.
-
Infusion of IOV-4001 for advanced melanoma and lung cancer
This study is testing a new treatment called IOV-4001 to see if it can help adults with advanced melanoma and lung cancer by targeting and killing their tumor cells.
-
New radiotherapy approach for advanced lung cancer
This study is testing a new type of radiotherapy for patients with advanced lung cancer who can't have regular treatment to see if it can help them live longer and feel better.
Related topics
Quick answers
How many Stage III Non-small Cell Lung Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Germany (1 trial), Switzerland (1 trial), Netherlands (1 trial), Denmark (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.